Spring Research Update Meeting 2025
Our 2025 Spring Research Update Meeting will take place at BMA House, home of the British Medical Association, in Tavistock Square, London on 24 March where we invite guests to an inspiring agenda of some of the most up to date news of our funded...
Learn more
Tough Mudder 2025
Get ready to get muddy! Tough Mudder is the ultimate obstacle challenge that will test your physical strength, stamina and mental determination. Run, climb and crawl for #TeamCure and prove to your friends just how tough you really are! Choose your location When you join...
The new Multi-arm Multi-stage MAMS trial model for Parkinson’s
One of the most frustrating aspects of the way we currently conduct clinical trials is the long delays between studies. Multi-Arm, Multi-Stage (or MAMS) clinical trials may represent a solution to this cumbersome problem.
Drug repurposing for Parkinson’s – No Silver Bullet 4 Parkinson’s webinar
Cure Parkinson’s funded researcher Dr Lorraine Kalia will be presenting the NoSilverBullet4PD webinar this September discussing ‘Drug repurposing for PD therapies’.
Preliminary phase 2 trial results of lixisenatide presented
A one-year, phase 2 clinical trial of Type 2 diabetes drug lixisenatide has reported positive early results, which indicate that the treatment may slow the progression of motor (or movement) symptoms. Preliminary results of the LixiPark study were presented at the International Parkinson and Movement…
Aspen starts phase 1 stem cell transplant clinical trial
An experimental treatment for Parkinson’s involves the replacement of the lost dopamine neurons by transplanting new cells into the brain. Biotech company Aspen Neuroscience will soon be starting a clinical trial in the US exploring this potential therapy in people with Parkinson’s.